Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Piscitelli

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|May 11, 2012
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptorFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
The International Journal of Biochemistry & Cell Biology|April 22, 2009
Study of the effects of a new pyrazolecarboxamide: changes in mitochondria and induction of apoptosisVincenzo Giansanti, Tania Camboni, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|September 7, 2007
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activityGiuseppe La Regina, Antonio Coluccia, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|March 4, 2011
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|February 26, 2008
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamidesRomano Silvestri, Maria Grazia Cascio, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|April 16, 2010
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregationCarlo Ballatore, Kurt R Brunden, Francesco Piscitelli, et al.
Bioorganic & Medicinal Chemistry|June 22, 2012
Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure-activity relationship leads to selection of candidates with desirable in vivo propertiesCarlo Ballatore, Alex Crowe, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|August 26, 2011
Cyclopentane-1,3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonistsCarlo Ballatore, James H Soper, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|May 26, 2006
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamideRino Ragno, Antonio Coluccia, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|June 21, 2012
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitorsGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|May 11, 2012
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptorFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
The International Journal of Biochemistry & Cell Biology|April 22, 2009
Study of the effects of a new pyrazolecarboxamide: changes in mitochondria and induction of apoptosisVincenzo Giansanti, Tania Camboni, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|September 7, 2007
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activityGiuseppe La Regina, Antonio Coluccia, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|March 4, 2011
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|February 26, 2008
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamidesRomano Silvestri, Maria Grazia Cascio, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|April 16, 2010
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregationCarlo Ballatore, Kurt R Brunden, Francesco Piscitelli, et al.
Bioorganic & Medicinal Chemistry|June 22, 2012
Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure-activity relationship leads to selection of candidates with desirable in vivo propertiesCarlo Ballatore, Alex Crowe, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|August 26, 2011
Cyclopentane-1,3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonistsCarlo Ballatore, James H Soper, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|May 26, 2006
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamideRino Ragno, Antonio Coluccia, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|June 21, 2012
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitorsGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Pageof 4